NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -25.33% | -25.74% | -19.50% | -9.15% | -13.24% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -65.68% | -61.77% | -53.74% | -26.91% | -19.82% |
Operating Income | 65.68% | 61.77% | 53.74% | 26.91% | 19.82% |
Income Before Tax | 57.71% | 54.68% | 48.25% | 28.23% | 20.15% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 57.71% | 54.68% | 48.25% | 28.23% | 20.15% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 57.71% | 54.68% | 48.25% | 28.23% | 20.15% |
EBIT | 65.68% | 61.77% | 53.74% | 26.91% | 19.82% |
EBITDA | 66.34% | 62.62% | 54.65% | 27.49% | 20.31% |
EPS Basic | 61.02% | 58.19% | 52.55% | 36.29% | 28.84% |
Normalized Basic EPS | 69.71% | 64.38% | 58.17% | 36.29% | 29.82% |
EPS Diluted | 61.02% | 58.19% | 52.55% | 36.29% | 28.84% |
Normalized Diluted EPS | 69.71% | 64.38% | 58.17% | 36.29% | 29.82% |
Average Basic Shares Outstanding | 15.48% | 10.73% | 9.07% | 12.48% | 12.69% |
Average Diluted Shares Outstanding | 15.48% | 10.73% | 9.07% | 12.48% | 12.69% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |